Emovid
Emovid is a startup headquartered in Seattle, United States, founded in 2023. It has raised at least $6.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Emovid has raised at least $6.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Emovid sits inside the Seattle and Redmond R&D ecosystem in the Global R&D Labs Directory.
Other startups in Seattle
- 98point6 Technologies
- Accipiter Biosciences
- Adronite
- Aether Studios
- Aggro Crab
- Arrived Holdings
- AtmoCooling
- Automera US
- Better Science
- Bond Communications
- Bonum Therapeutics
Related
- Innovation profile of Seattle
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Emovid do?
Emovid is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Emovid raised?
At least $6.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Emovid based?
Emovid is headquartered in Seattle, United States.
When was Emovid founded?
Emovid was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.